All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Best Compounded Semaglutide Providers 2026

The best compounded semaglutide providers in 2026, ranked by pharmacy quality, medical oversight, pricing, and patient safety.

By Dr. Rachel Nguyen, DO|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Rachel Nguyen, DO · Reviewed by Dr. David Kim, MD, FACE

Best Compounded Semaglutide Providers 2026 custom 2026 header image for Provider Comparisons
Custom header image for Best Compounded Semaglutide Providers 2026, Provider Comparisons, and better treatment decision-making.
In This Article

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Search and AI answer brief

Practical answer: Best Compounded Semaglutide Providers 2026

The best compounded semaglutide providers in 2026, ranked by pharmacy quality, medical oversight, pricing, and patient safety.

Short answer

The best compounded semaglutide providers in 2026, ranked by pharmacy quality, medical oversight, pricing, and patient safety.

Search intent

This page answers a specific Provider Comparisons question rather than a generic overview.

What to verify

semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Compounded semaglutide has become the most accessible way for Americans to access GLP-1 weight loss therapy without spending $1,300/month on brand-name Wegovy. But the compounding market varies wildly in quality.

Compounded semaglutide has become the most accessible way for Americans to access GLP-1 weight loss therapy without spending $1,300/month on brand-name Wegovy. But the compounding market varies wildly in quality. Some providers source from rigorously regulated 503B pharmacies. Others use 503A pharmacies with less oversight, or worse, leave patients guessing about where their medication comes from.

We investigated 12 compounded semaglutide providers, focusing specifically on pharmacy sourcing, medical oversight, and medication quality. Here are the ones we trust.

Our Top Picks

  1. Ro Body : Best pharmacy quality (in-house 503B compounding)
  2. FormBlends : Best physician oversight with transparent 503B sourcing
  3. Hims/Hers : Best large-scale compounded semaglutide provider
  4. Henry Meds : Best budget compounded semaglutide
  5. Alpha Medical : Solid mid-range option with good provider access

Detailed Reviews

#1. Ro Body

Ro stands alone in one critical respect: they operate their own pharmacy. This gives them direct control over the compounding process, which eliminates the supply chain opacity that plagues much of the compounded medication market. For a complete cost breakdown, see our cheapest GLP-1 without insurance. For a complete cost breakdown, see our semaglutide pricing comparison.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92From $299/mo, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus

When your semaglutide comes from Ro's in-house pharmacy, you know exactly where it was made, under what conditions, and with what quality controls. Their physicians order labs as part of the standard protocol, and dosing adjustments are based on objective data rather than patient self-reporting alone.

Pricing starts at $149/month for low doses and scales upward. The in-house pharmacy advantage justifies Ro's position at the top of this list.

Pros:

  • In-house pharmacy with full quality control
  • Lab-based monitoring standard
  • Eliminates third-party supply chain risk
  • Physician-led care

Cons:.

  • Price scales with dose (up to $249/month)
  • State availability is limited
  • No coaching or lifestyle support

#2. FormBlends

FormBlends sources compounded semaglutide exclusively from 503B outsourcing facilities, and they're transparent about which pharmacies they use. This matters because 503B pharmacies operate under FDA oversight with current good manufacturing practices (cGMP), batch testing, and regular inspections.

Beyond pharmacy quality, FormBlends provides the most engaged physician oversight we found among compounded semaglutide providers. Your prescriber builds a personalized dosing protocol, actively monitors your progress, and adjusts your treatment based on response. At $199/month with medication included, the combination of pharmacy transparency and clinical care is strong.

Pros:

  • Transparent 503B pharmacy sourcing
  • Active physician management of dosing and side effects
  • Personalized protocols rather than standardized titration
  • Also offers compounded tirzepatide and peptide therapy

Cons:

  • $50/month more than the cheapest options
  • No in-house pharmacy (relies on external 503B partners)
  • Smaller patient capacity

#3. Hims/Hers

Hims/Hers is the largest compounded semaglutide provider by volume, and their scale has allowed them to negotiate favorable terms with 503B pharmacies. Compounded semaglutide runs $175/month, the platform is well-designed, and fulfillment is consistently fast.

The medical oversight is competent but volume-driven. Providers follow structured protocols, which ensures consistency but limits personalization. For medically straightforward patients, this model works well.

Pros:

  • Scale provides reliable supply and fast fulfillment
  • Competitive pricing at $175/month
  • Well-built digital platform
  • Consistent protocol-driven care

Cons:

  • Limited personalization
  • Provider continuity is weak
  • Less transparency about specific pharmacy partners

#4. Henry Meds

Henry Meds offers compounded semaglutide at $149/month, making them the most affordable provider on this list. Their 503B pharmacy sourcing is verified, and the medication quality has been consistently reported as reliable by patients.

The trade-off is minimal clinical engagement. Monthly check-ins are brief and standardized. For patients who are medically straightforward and primarily need affordable access, Henry Meds fills that niche well.

Pros:

  • Lowest price on this list at $149/month
  • 503B pharmacy sourcing confirmed
  • No hidden fees
  • Fast enrollment

Cons:

  • Medical oversight is minimal
  • No lab monitoring
  • Limited dose customization

#5. Alpha Medical

Alpha Medical provides compounded semaglutide at approximately $199/month. Their platform offers good provider messaging, and physician access is solid. The 503B sourcing is verified, and the overall experience is professional.

Alpha sits in the middle of this list because they don't excel in any single area but deliver competent care across the board. The provider access is better than Henry Meds, the pricing is similar to FormBlends, and the platform is functional.

Pros:

  • Good provider access and messaging
  • 503B pharmacy sourcing
  • Professional platform experience

Cons:

  • Doesn't stand out in any single category
  • Less brand recognition than major competitors
  • Limited additional therapy options

How We Evaluated

Compounded semaglutide is only as good as the pharmacy producing it and the physician supervising its use. Our evaluation reflected this:

Get compounded semaglutide from $99/mo

Free provider review, personalized dosing, and ongoing support included.

Start Free Assessment →
  • Pharmacy quality and transparency (35%): We prioritized providers who use 503B outsourcing facilities and are transparent about their pharmacy partners. In-house pharmacy operations received the highest marks. We contacted each provider to verify their pharmacy sourcing claims.
  • Medical oversight (25%): How actively the prescribing physician manages your care, including lab monitoring, dosing adjustments, and side effect management
  • Pricing (20%): All-in monthly cost at maintenance doses
  • Fulfillment reliability (10%): Shipping speed, consistency, and handling of supply disruptions
  • Patient safety protocols (10%): Screening processes, contraindication checks, and emergency protocols

FAQ

What is the difference between a 503A and 503B compounding pharmacy?

503A pharmacies compound medications based on individual prescriptions, typically for local patients. They're regulated by state boards of pharmacy. 503B outsourcing facilities can compound larger batches without patient-specific prescriptions and are registered with and inspected by the FDA. 503B pharmacies must follow current good manufacturing practices (cGMP), which provides a higher standard of quality control. For compounded semaglutide, 503B sourcing is the safer choice.

Is compounded semaglutide FDA-approved?

No. The FDA approves specific drug products (like Wegovy), not compounded versions. But compounded semaglutide is legal when produced by registered 503B outsourcing facilities. The FDA has taken enforcement action against providers using unregistered or non-compliant pharmacies, which underscores the importance of verifying your provider's pharmacy sourcing.

How do I verify that a provider uses a legitimate 503B pharmacy?

Ask the provider directly which pharmacy or pharmacies compound their semaglutide. Then check the FDA's list of registered 503B outsourcing facilities at fda.gov. Legitimate providers should be willing to share this information. If a provider refuses to disclose their pharmacy partner, consider that a red flag.

Can compounded semaglutide have different concentrations?

Yes. Compounded semaglutide is typically available in multiple concentrations, allowing for precise dosing with smaller injection volumes. Your provider should clearly communicate the concentration and injection volume for your specific prescription. Concentration misunderstandings are a common source of dosing errors, so make sure this is clearly documented in your treatment plan.

What happens to compounded semaglutide if the FDA changes its regulations?

The legal basis for compounded semaglutide relates to drug shortage designations and the regulatory framework for 503B pharmacies. If the FDA removes semaglutide from the shortage list or changes enforcement policies, some compounded products could be affected. Reputable providers monitor regulatory developments and will communicate changes to patients proactively.


Want compounded semaglutide from a provider that's transparent about sourcing? Start your FormBlends consultation and get physician-supervised compounded GLP-1 therapy from verified 503B pharmacies.

Research Snapshot

Ranked provider guide
Page type
Ranked provider guide
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Alpha Medical official source
Official source
Calibrate official source
Official source
Found official source
Official source
Henry Meds official source
Official source
Hers official source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Best Compounded Semaglutide Providers 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

Best Compounded Semaglutide Providers 2026 should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

The best compounded semaglutide providers in 2026, ranked by pharmacy quality, medical oversight, pricing, and patient safety. "Best Compounded Semaglutide Providers 2026" earns its keep when it helps a reader move from a broad question to a cleaner next step. This is a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm, and the reader usually needs help with comparison and decision support. Pay extra attention to semaglutide, cost and coverage, provider access, safety and pharmacy quality and related tags such as GLP-1, weight management, semaglutide. Read the opening answer first, then check the evidence and safety sections before acting on the recommendation.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify total monthly cost, refill timing, dose escalation pricing, and what is included before paying.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Best Compounded Semaglutide Providers 2026

For this provider comparisons page, the 2026 refresh focuses on semaglutide, tirzepatide, cash-pay pricing, safety signals, best, compounded so the article stays close to the question behind "Best Compounded Semaglutide Providers 2026".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Best Compounded Semaglutide Providers 2026 from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Best Compounded Semaglutide Providers 2026 custom 2026 image for provider comparisons on FormBlends

Custom 2026 image for Best Compounded Semaglutide Providers 2026, provider comparisons, and better treatment decision-making.

Image description: Unique image for this page covering Best Compounded Semaglutide Providers 2026, provider comparisons, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.

Written by Dr. Rachel Nguyen, DO

Obesity Medicine Specialist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.